Viridian Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 19.9 USD | 34,29 USD | 13,18 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 36,125 USD | 9 | 5 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 110.427.682 | 17,78 | 7,54 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Viridian Therapeutics Inc
Mitarbeiter 252
Handelsplatz NASDAQ
Ticker Symbol VRDN
IPO Datum 2014-06-18
Adresse 221 Crescent Street, Waltham, MA, United States, 02453
Webseite https://www.viridiantherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Stephen F. Mahoney J.D., MBA | CEO, President & Director |
| 2 | Mr. Seth Harmon | Chief Financial Officer |
| 3 | Mr. Thomas W. Beetham J.D., MBA | Chief Operating Officer |
| 4 | Ms. Jennifer Tousignant J.D. | Chief Legal Officer & Corporate Secretary |
| 5 | Dr. Radhika Tripuraneni M.D., M.P.H. | Chief Medical Officer |
| 6 | Dr. Eric N. Olson Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| 7 | Dr. Michael R. Bristow M.D., Ph.D. | Co-Founder & Member of the Scientific Advisory Board |
| 8 | Dr. Marvin H. Caruthers Ph.D. | Co-Founder & Scientific Advisory Board Member |
| 9 | Mr. Vahe Bedian Ph.D. | Co-Founder & Scientific Advisor |
| 10 | Ms. Melissa Manno | Chief Human Resources Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Bellevue Group AG | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Fairmount Funds Management LLC | 0,00% | 0,00 Mio. USD |
| 8 | VR Adviser, LLC | 0,00% | 0,00 Mio. USD |
| 9 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 10 | Paradigm Biocapital Advisors LP | 0,00% | 0,00 Mio. USD |
| 11 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 12 | Kynam Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 13 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 15 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | Novo A/S | 0,00% | 0,00 Mio. USD |
| 17 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 18 | TANG CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |
| 19 | Fisher Asset Management, LLC | 0,00% | 0,00 Mio. USD |
| 20 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |